Siegfried Holding AGXSWX:SFZN +1.60%94 Net Margin % is 14.58% as of Dec. 2025, which is 84% above its 10-year median of 7.94. GuruFocus rates XSWX:SFZN with a GF Score™ of 94/100 and a GF Value™ of CHF91.94 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Siegfried Holding AG ranks better than 72.7% on this metric.
The historical rank and industry rank for Siegfried Holding AG's Net Margin % or its related term are showing as below:
XSWX:SFZN'
s Net Margin % Range Over the Past 10 Years
Min: 3.89 Med: 7.94 Max: 12.73
Current: 12.7
XSWX:SFZN's Net Margin % is ranked better than 72.7% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs XSWX:SFZN: 12.70
Siegfried Holding AG (XSWX:SFZN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Siegfried Holding AG Net Margin % Related Terms
Siegfried Holding AG Net Margin % Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SFZN vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) has a Net Margin % of 14.58% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Siegfried Holding AG and its competitors. This is 84% above median its historical median of 7.94. Over the past decade, Siegfried Holding AG's Net Margin % has ranged from 3.89 to 12.73. According to the industry distribution chart, Siegfried Holding AG ranks #261 out of 956 companies in the Drug Manufacturers industry, placing it in the top 27.3%.
Is Siegfried Holding AG's Net Margin % too high?
Siegfried Holding AG's current Net Margin % of 14.58% is 84% above median its 10-year median of 7.94. Over the past 10 years, this metric has ranged from a low of 3.89 to a high of 12.73. The Drug Manufacturers industry median Net Margin % is 5.56. Siegfried Holding AG's value of 14.58% is 162.2% above this industry median. Based on the distribution chart, Siegfried Holding AG ranks #261 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #261 out of 956 companies for Net Margin %. This puts Siegfried Holding AG in the upper half of its industry. The industry median Net Margin % is 5.56. Siegfried Holding AG's value of 14.58% is 162.2% above this benchmark. Historically, Siegfried Holding AG's own Net Margin % has ranged from 3.89 to 12.73 over the past decade. While the company's 10-year median is 7.94 vs. the industry median of 5.56, Siegfried Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current Net Margin % of 14.58% is 162.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current Net Margin % is 14.58%, which is 84% above median its own 10-year median of 7.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF91.94, compared to a current price of CHF69.65 — trading 24.2% below its estimated fair value. The current Net Margin % is 14.58%, which is 84% above median its 10-year median of 7.94 and 162.2% above the Drug Manufacturers industry median of 5.56. Siegfried Holding AG's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Net Margin % is 14.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF69.65 is trading 24.2% below its estimated GF Value™ of CHF91.94.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
Net Margin %: 14.58% (84% above median its 10-year median of 7.94)
GF Value™: CHF91.94 vs. price of CHF69.65 (24.2% below fair value)
Industry Position: 162.2% above the Drug Manufacturers median (#261 of 956)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
94GF Score
Get the complete analysis for XSWX:SFZN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
